Quick Answer
Verrica Pharmaceuticals Inc. reported Net Income of -$17.89 million for fiscal year 2025.
Verrica Pharmaceuticals Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$17.89M | +76.6% |
| 2024 | -$76.58M | -14.3% |
| 2023 | -$67.00M | -173.6% |
| 2022 | -$24.49M | +30.2% |
| 2021 | -$35.08M | +17.8% |
| 2020 | -$42.69M | -51.4% |
| 2019 | -$28.21M | -36.6% |
| 2018 | -$20.65M | -363.1% |
| 2017 | -$4.46M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$274.0K | +98.8% | -234.3% |
| June 30, 2025 | $204.0K | +101.2% | +102.1% |
| March 31, 2025 | -$9.74M | +52.1% | +57.4% |
| September 30, 2024 | -$22.86M | +7.8% | -33.0% |
| June 30, 2024 | -$17.19M | -56.4% | +15.5% |
| March 31, 2024 | -$20.33M | -208.6% | +18.0% |
| September 30, 2023 | -$24.80M | -29981.9% | -125.7% |
| June 30, 2023 | -$10.99M | -8.1% | -66.8% |
- Verrica Pharmaceuticals Inc. showed an increase of +76.6% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Verrica Pharmaceuticals Inc.’s net income has declined by 301.1% (from -$4.46 million to -$17.89 million).
- The most recent figure is from Verrica Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: